Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jessica Randolph

Podiatrist, Foot & Ankle Surgery Glendale, AZ Doctor of Podiatric Medicine

NPI 1053788000 CMS profile 4388765

6677 W Thunderbird Rd Ste J171, Glendale, AZ 85306

Open in the dashboard

General payments

$39,804

516 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jessica Randolph of Glendale, AZ is reported in the CMS Open Payments database as having received $39,804 across 516 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $12,448 138
2024 General $6,725 103
2023 General $9,236 102
2022 General $4,963 61
2021 General $2,862 58
2020 General $2,763 35
2019 General $807 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jessica Randolph
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Jessica Randolph were reported at $12,448. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Jessica Randolph Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $807 $389 $118–$1,406 $163
2020 $2,763 $191 $62–$691 $114
2021 $2,862 $329 $104–$1,341 $132
2022 $4,963 $419 $125–$1,611 $149
2023 $9,236 $377 $128–$1,164 $160
2024 $6,725 $394 $134–$1,168 $164
2025 $12,448 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Orthofix Medical, Inc. $12,261 146 payments
  2. Acera Surgical, Inc. $5,571 43 payments
  3. Stryker Corporation $4,971 51 payments
  4. Smith+Nephew, Inc. $4,128 43 payments
  5. Medline Industries, Inc. $2,536 13 payments
  6. Musculoskeletal Transplant Foundation Inc. $1,857 4 payments
  7. TriMed, Inc. $1,586 5 payments
  8. Treace Medical Concepts, Inc. $946 12 payments
  9. Medical Device Business Services, Inc. $839 6 payments
  10. Forthright Medical-AZ, LLC $837 42 payments
  11. Other $4,273 151 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $20,887 116 payments
  2. Food and Beverage $15,734 394 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,144 4 payments
  4. Gift $22 1 payment
  5. Education $18 1 payment
Products named General payments · program years 2019–2025
  1. TrueLok $17,417 168 payments
  2. Restrata Wound Matrix $5,571 43 payments
  3. PICO $3,161 19 payments
  4. Versajet $2,578 12 payments
  5. COLLAGENASE SANTYL $1,615 11 payments
  6. GRAFIX $1,570 8 payments
  7. HOFFMANN $1,531 18 payments
  8. OASIS $1,072 6 payments
  9. Allevyn Gentle Border 10 x 10cm Ctn 10 $1,025 5 payments
  10. ACTICOAT 4" X 4" $1,025 5 payments
  11. Other $13,480 346 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 78 billing codes

Paid by Medicare

$76,783

Medicare's payments for the services billed

Medicare patients

81

Average age 72

Services billed

951

34 women, 47 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 62%
Diabetes 60%
Chronic kidney disease 49%
Ischemic heart disease 47%
Heart failure 33%
Depression 30%
Atrial fibrillation 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DALVANCE
  • AbbVie, Inc. $369
$369 — —
TEFLARO
  • AbbVie, Inc. $84
$84 — —
NUZYRA
  • Paratek Pharmaceuticals, Inc. $39
$39 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

516 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record